This proposal requests continued support for the Medical Scientist Training Program (MSTP) at Vanderbilt University. The primary goal of the Vanderbilt MSTP is to identify, mentor, and foster the careers of future leaders in academic medicine who are dedicated to improving human health through research. The program is based on rigorous training in clinical medicine and scientific inquiry. Successful completion of the MSTP leads to both M.D. and Ph.D. degrees. Core elements of the program developed specifically for dual-degree students include a literature-based seminar series, clinical preceptorship program, data club, leadership workshop, career development workshop, physician-scientist speaker series, and an annual retreat. Formal instruction in responsible conduct of research is provided throughout the curriculum. An innovative advising college program offers opportunities for student advising by faculty members and senior trainees. The MSTP supports students enrolled at both Vanderbilt University and Meharry Medical College. Seventy-four percent of our graduates with established careers hold academic or private-sector research positions, including two deans and 20 full professors. More recent graduates still in training have been placed in superb residencies and fellowships. The 84 current trainees come from 59 colleges and universities distributed across North America. The nationwide applicant pool results from concerted recruiting efforts, including those focused on the recruitment of students from groups underrepresented in medicine. In the current year, 275 applications have been received, from which 12 students will be selected to enter the incoming class. The proposed goal is to increase the size of the program to a steady state of 96 students over the next five years. The educational environment for physician-scientists at Vanderbilt University is outstanding. Extramural research funding has increased from $256 million to $389 million since 2003. Building on established strengths in cancer biology, cell biology, clinical pharmacology, diabetes, signal transduction, toxicology, and vaccine science, new areas of research emphasis include biomedical informatics, chemical and physical biology, genetics, imaging sciences, neurosciences, and structural biology. The proposal requests an increase in funded positions to 32 (29 for Vanderbilt;3 for Meharry) during the five-year project period. Ongoing support for the Vanderbilt MSTP is based on the strength of the applicant pool, enhanced opportunities for physician-scientist training, and an institutional commitment to the education of leaders in biomedical research. The Vanderbilt Medical Scientist Training Program supports the training of physician-scientists who seek to improve human health through basic, translational, or clinical research. The broad public health significance of this program will be realized through the academic and scholarly accomplishments of the trainees, with connections to both the direct treatment of patients in the clinical setting and the discovery of basic disease mechanisms and new therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007347-34
Application #
8286145
Study Section
Special Emphasis Panel (ZGM1-BRT-2 (MB))
Program Officer
Preusch, Peter C
Project Start
1977-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
34
Fiscal Year
2012
Total Cost
$1,092,400
Indirect Cost
$46,696
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Koethe, John R; McDonnell, Wyatt; Kennedy, Arion et al. (2018) Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 77:e14-e21
Donahue, Manus J; Achten, Eric; Cogswell, Petrice M et al. (2018) Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease. J Cereb Blood Flow Metab 38:1391-1417
McKenna, Matthew T; Weis, Jared A; Quaranta, Vito et al. (2018) Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations. Ann Biomed Eng 46:899-911
Kozek, Krystian A; Du, Yu; Sharma, Swagat et al. (2018) Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels. ACS Chem Neurosci :
Sundermann, Alexandra C; Saum, Keith; Conrad, Kelsey A et al. (2018) Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth. Blood Adv 2:3088-3096
Athmer, Jeremiah; Fehr, Anthony R; Grunewald, Matthew E et al. (2018) Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses. MBio 9:
Feng, QiPing; Wei, Wei-Qi; Chung, Cecilia P et al. (2018) Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. PLoS Med 15:e1002642
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Zamora, Paula F; Hu, Liya; Knowlton, Jonathan J et al. (2018) Reovirus Nonstructural Protein ?NS Acts as an RNA Stability Factor Promoting Viral Genome Replication. J Virol 92:
Earl, David C; Ferrell Jr, P Brent; Leelatian, Nalin et al. (2018) Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics. Nat Commun 9:39

Showing the most recent 10 out of 536 publications